This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Eli Lilly &amp; Co. (LLY) slipped 2.26% to $977.25 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&amp;P 500 Index falling 1.52% to 6,672.62 and Dow Jones Industrial Average falling 1.56% to 46,677.85.
This was the stock's third consecutive day of losses.
Eli Lilly &amp; Co. closed 13.82% below its 52-week high of $1,133.95, which the company achieved on January 8th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson &amp; Johnson (JNJ) fell 0.39% to $242.04, Pfizer Inc. (PFE) fell 1.61% to $26.86, and AbbVie Inc. (ABBV) fell 1.01% to $225.37.
Trading volume (2.3 M) remained 803,502 below its 50-day average volume of 3.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-12-26 1632ET

ABBV

Eli Lilly & Co. (LLY) shares fell 2.26% to $977.25 on Thursday, marking the third consecutive day of losses. The stock is now 13.82% below its 52-week high of $1,133.95. In comparison, competitors like Johnson & Johnson (JNJ), Pfizer Inc. (PFE), and AbbVie Inc. (ABBV) also experienced declines, but to a lesser extent. The overall market was down, with the S&P 500 Index falling 1.52% and the Dow Jones Industrial Average down 1.56%. Trading volume was below average at 2.3 million shares.

- Shares of Eli Lilly & Co. (LLY) decreased by 2.26% to $977.25 in a poor trading session, with the S&P 500 falling 1.52% and the Dow Jones down 1.56%.  
- This marked the stock's third consecutive day of losses, and it closed 13.82% below its 52-week high of $1,133.95.  
- Eli Lilly underperformed relative to competitors like Johnson & Johnson, Pfizer, and AbbVie, all of which also experienced declines.

Dow Jones

Abbvie

Johnson & Johnson

Eli Lilly

Pfizer

Bristol Myers Squibb

Health Care Select Sector SPDR

iShares US Pharma

ALPS Medical Breakthrough

SPDR S&P Biotech

Direxion Daily LLY Bull 2X Shares

Defiance Daily Target 2X Long LLY ETF

VanEck Biotech ETF

VG Health

Direxion Pharma & Medical Bull 3X

iShares Global Healthcare

Eli Lilly & Co. Stock Underperforms Thursday When Compared To Competitors